Joseph L. Moskowitz Sells 1,000 Shares of Aflac Incorporated (NYSE:AFL) Stock

Aflac Incorporated (NYSE:AFL) Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the sale, the director now directly owns 25,393 shares of the company’s stock, valued at approximately $2,733,048.59. This trade represents a 3.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Aflac Stock Down 1.5 %

Shares of AFL stock opened at $104.67 on Thursday. The firm has a fifty day moving average of $105.24 and a 200-day moving average of $107.70. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12-month low of $79.31 and a 12-month high of $115.50. The company has a market capitalization of $57.21 billion, a price-to-earnings ratio of 10.90, a P/E/G ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, equities research analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Keefe, Bruyette & Woods lowered their target price on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research note on Wednesday, February 12th. Barclays lowered their target price on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, February 7th. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. JPMorgan Chase & Co. upped their target price on shares of Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research note on Tuesday, January 7th. Finally, Morgan Stanley upped their target price on shares of Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $103.36.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in AFL. Pettinga Financial Advisors LLC acquired a new position in Aflac during the third quarter worth $203,000. CWA Asset Management Group LLC acquired a new position in Aflac during the third quarter worth $810,000. XML Financial LLC acquired a new stake in Aflac in the third quarter valued at $207,000. Covestor Ltd lifted its stake in Aflac by 41.8% in the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after acquiring an additional 107 shares during the last quarter. Finally, Axxcess Wealth Management LLC lifted its stake in Aflac by 95.9% in the third quarter. Axxcess Wealth Management LLC now owns 6,143 shares of the financial services provider’s stock valued at $687,000 after acquiring an additional 3,007 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.